'Good' bug may have a role in bowel disease

December 11, 2012, University of Aberdeen

(Medical Xpress)—A bug thought to be one of the 'good bacteria' in our gut may actually have a role in the development of a bowel disorder that is on the rise in Scotland.

That is the possibility being raised by University of Aberdeen scientists who have published research which found significantly high levels of Faecalibacterium prausnitizii in the colon of with Crohn's disease.

Up until now the bug - one of the most common found in the gut - has been associated with Crohn's disease but in a 'protective' way, because other studies have found it in low levels in patients with Crohn's, and because it has anti-inflammatory properties.

The findings have surprised scientists because it goes against current thinking. However they stress more research is needed into F. prausnitzii before they really understand the part the bug may play in the disorder, which has increased five-fold in Scottish children over the last 35 years.

Researchers recruited children from Aberdeen, Glasgow and Dundee onto their study which was looking for potential bacterial triggers for inflammatory bowel disease (IBD) - Crohn's disease and ulcerative colitis - which affects around 6% of the Scottish population.

Children were recruited when they attended hospital for a to confirm or rule out whether they had IBD.

Dr Richard Hansen, Clinical Lecturer in at the University of Aberdeen, was the study co-ordinator for the work just published in the .

He said: "There is a lot of research into inflammatory bowel disease but much of that has focused on Crohn's disease and ulcerative colitis in adults.

"We wanted to study as 'pure' a population as possible - by that I mean people who have not yet had an intervention or treatment for their IBD, and are less likely to have other illnesses, or to have made , such as being a smoker or .

"Ours is a unique study because this type of research cohort has not been studied by IBD researchers before."

Blood and tissue samples were taken from patients who were recruited over a three year period and were aged between two and 16 years.

Recruits from this study came from the larger BISCUIT- Bacteria in in Scottish Children Undergoing Investigation before Treatment - study which recruited a total of 100 children over three years, including 44 presenting for the first time with IBD and 42 who had a normal bowel.

Thirty four recruits were selected for a more detailed analysis, including 11 with Crohn's disease, 11 with and 12 'controls' with a normal bowel.

Bacteria in the samples were then identified using the latest DNA 'sequencing' technology.

Dr Georgina Hold, Senior Lecturer in Gastroenterology, at the University of Aberdeen and senior author on the study, said: "We found no significant changes in types of bacteria present across the three groups although there was less variety in the species of bacteria in kids with Crohn's disease.

"However we did see a significant increase in the bacterium Faecalibacterium prausnitzii in children with Crohn's disease.

"This was a surprise because other studies of patients with Crohn's disease have reported a reduction in levels of this bug which supports current thinking that it is somehow protective.

"However our finding suggests that this particular bug may not always be a 'good' bacterium and may actually contribute to the development of the disease."

Dr Hansen added: "We now plan to carry out a further study to look at Faecalibacterium prausnitzii specifically and to relate this to a liquid diet treatment that is commonly used to treat in children.

"We also need to understand more about how to restore and retain the normal bacterial communities within the gut."

Explore further: Study on inflammatory bowel disease in First Nations people adds to understanding of disease

Related Stories

Study on inflammatory bowel disease in First Nations people adds to understanding of disease

April 10, 2012
Inflammatory bowel disease is relatively rare in Canadian First Nations people but common in white people, possibly due to different genetic variants, according to a new study in CMAJ (Canadian Medical Association Journal) ...

Inflammatory bowel disease emerges as a global disease

January 4, 2012
The incidence and prevalence of inflammatory bowel disease (IBD) are increasing with time and in different regions around the world, according to a new study in Gastroenterology, the official journal of the American Gastroenterological ...

Recommended for you

Chronic inflammation causes loss of muscle mass during aging

January 12, 2018
People start losing muscle mass at the age of 40—about some 10 percent of the total muscle mass for each 10-year period, which may lead to fall-related injuries, slowing metabolism and reduced quality of life. Today, very ...

Breathing exercises help asthma patients with quality of life

December 13, 2017
A study led by the University of Southampton has found that people who continue to get problems from their asthma, despite receiving standard treatment, experience an improved quality of life when they are taught breathing ...

Study highlights the need for research into prevention of inflammatory bowel disease

December 7, 2017
Countries in Africa, Asia, the Middle East and South America have seen a rise in incidence of inflammatory bowel disease as they have become increasingly industrialised and westernised, a new study has found.

Air pollution can increase asthma risk in adults, even at low levels

November 24, 2017
Living close to a busy road can be bad for your respiratory health if you are middle aged, new Australian research has found.

Evidence found of oral bacteria contributing to bowel disorders

October 20, 2017
(Medical Xpress)—An international team of researchers has found evidence that suggests certain types of oral bacteria may cause or exacerbate bowel disorders. In their paper published in the journal Science, the group describes ...

New compound discovered in fight against inflammatory disease

September 22, 2017
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.